3rd How I Manage CAR-T Therapies and Bispecific Antibodies for my Patients

3^rd How I Manage:
CAR-T Therapies and Bispecific Antibodies for my patients

September 26-28, 2025 – Clarion Hotel Stockholm

#ESHCART2025

Chairs: Caron Jacobson, Ulrich Jäger, Marie José Kersten

REGISTRATION IS OPEN!

ABOUT THE CONFERENCE:

The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants.

In addition to the scientific and medical issues addressed during the conference, the questions of affordability and access to these novel expensive treatments will be tackled.

This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!

MAIN SCIENTIFIC TOPICS:

• Non-hodgkin lymphoma
• Multiple myeloma
• Novel indications of CAR T-cell therapy
• CAR-T vs bispecific antibody in multiple myeloma
• Access to CAR-T and bispecific across the globe
• Mechanism of action and resistance to bispecifics
• Predictors of response and toxicity of CAR and bispecific
• Access issues in CAR T-cell treatment
• 1st line high-risk large B-cell lymphoma
• Real world data for CAR-T and bispecific
• Next Generation of CAR T-cell and bispecific antibody therapy
• Outsmarting the Escape Artist: resistance to CART immunotherapy

LEARNING OBJECTIVES:

• Understanding of the current landscape of bispecific antibodies in NHL and MM
• Understanding of the current landscape of CAR-T cell therapy in NHL and MM
• Novel approaches and technologies in the field
• Integration of novel therapies into current clinical practice
• Understanding the management of side effects of CAR T-cell therapy and bispecific antibodies
• Understand potential indications and sequencing of CAR-T cells and bispecifics

THE PROGRAMME WILL INCLUDE:
• Keynote lectures
• Case-based lectures
• Interactive Case Presentations
• Roundtables
• Panel Discussions
• Debates
• Poster Walks
• Meet the Expert Sessions
• Voting technology

For more information on this conference, please contact Changyi Jiang

This conference is a Face to Face meeting. No virtual attendance is scheduled.

Click HERE to read the final programme!

Submission for clinical cases and abstracts for an oral or a poster presentation is closed.
The deadline was June 29, 2025 (23:59 CEST)

Clinical Case Presentation:

• Clinical cases must be relevant to the topic of the meeting. 
• Maximum number of words: 500 
• Your clinical case will be submitted to review by conference chairpersons. 

 Abstracts:

• Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured. 
• Maximum number of words: 500 
• Your abstract will be submitted to review by conference chairpersons.

We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Rooms in the conference venue hotel (Clarion Hotel Stockholm) have been sold out.

Thank you for your understanding.

Clarion Hotel Stockholm

Ringvägen 98, 118 60 Stockholm, Sweden

REGISTRATION IS OPEN!

The registration fee for the ESH 3^rd How I Manage: CAR-T Therapies and Bispecific Antibodies for my patients is:

– 600€ for fully trained

– 300€ for in-training *

– 300€ Allied Health Professionals

– 600€ for Corporate

*A proof will be requested to confirm your status.

ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members a 20% discount on the conference registration fees.

This fee includes:

• Your seat in the Conference Room
• The conference materials,
• Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

REGISTER HERE